Sami Milouchi

Sami Milouchi

Auto-generated profile, based on publicly available information

Sami Milouchi

Tunisian Society of cardiology and cardiovascular surgery, tunis, Tunisia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Pregnancy Hypertension
Verified
Journal Article
Closed access
HAH. Ajmi
H. Ajmi
DAD. Abid
D. Abid
SMS. Milouchi
S. Milouchi
DLD. Louati
D. Louati
ASA. Sghaier
A. Sghaier
SKS. Kammoun
S. Kammoun

1 January 2020 in Pan African Medical Journal
Verified
Journal Article
Open access
SFSameh Ben Farhat
Sameh Ben Farhat
MSMaroua Salah
Maroua Salah
SMSami Milouchi
Sami Milouchi
Metastases to the heart and pericardium are much more common than primary malignant neoplasms. Primary malignant pericardial mesothelioma is a rare tumor that arises from the mesothelial cells of the pericardium. It is usually characterized by a delayed diagnosis, a low response to treatment, and a poor prognosis with an overall survival up to six months after the onset of symptoms. We report a rare case of a 32-year-old woman with primary pericardial malignant mesothelioma that was diagnosed 4 months after the onset of pericardial effusion as the first clinical manifestation.

27 December 2021 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
SCS. Charfeddine
S. Charfeddine
HIH. Ibnhadjamor
H. Ibnhadjamor
STS. Torjmen
S. Torjmen
SKS. Kraiem
S. Kraiem
RHRania Hammami
Rania Hammami
LAL. Abid
L. Abid

1 October 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
LALeila Abid
Leila Abid
IKIkram Kammoun
Ikram Kammoun
MHManel Ben Halima
Manel Ben Halima
SCSalma Charfeddine
Salma Charfeddine
HSHedi Ben Slima
Hedi Ben Slima
FAFaouzi Addad
Faouzi Addad
Background: The frequency of heart failure (HF) in Tunisia is on the rise and has now become a public health concern. This is mainly due to an aging Tunisian population (Tunisia has one of the oldest populations in Africa as well as the highest life expectancy in the continent) and an increase in coronary artery disease and hypertension. However, no extensive data are available on demographic characteristics, prognosis, and quality of care of patients with HF in Tunisia (nor in North Africa). Objective: The aim of this study was to analyze, follow, and evaluate patients with HF in a large nation-wide multicenter trial. Methods: A total of 1700 patients with HF diagnosed by the investigator will be included in the National Tunisian Registry of Heart Failure study (NATURE-HF). Patients must visit the cardiology clinic 1, 3, and 12 months after study inclusion. This follow-up is provided by the investigator. All data are collected via the DACIMA Clinical Suite web interface. Results: At the end of the study, we will note the occurrence of cardiovascular death (sudden death, coronary artery disease, refractory HF, stroke), death from any cause (cardiovascular and noncardiovascular), and the occurrence of a rehospitalization episode for an HF relapse during the follow-up period. Based on these data, we will evaluate the demographic characteristics of the study patients, the characteristics of pathological antecedents, and symptomatic and clinical features of HF. In addition, we will report the paraclinical examination findings such as the laboratory standard parameters and brain natriuretic peptides, electrocardiogram or 24-hour Holter monitoring, echocardiography, and coronarography. We will also provide a description of the therapeutic environment and therapeutic changes that occur during the 1-year follow-up of patients, adverse events following medical treatment and intervention during the 3- and 12-month follow-up, the evaluation of left ventricular ejection fraction during the 3- and 12-month follow-up, the overall rate of rehospitalization over the 1-year follow-up for an HF relapse, and the rate of rehospitalization during the first 3 months after inclusion into the study. Conclusions: The NATURE-HF study will fill a significant gap in the dynamic landscape of HF care and research. It will provide unique and necessary data on the management and outcomes of patients with HF. This study will yield the largest contemporary longitudinal cohort of patients with HF in Tunisia.

8 April 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
SCSonia Chabrak
Sonia Chabrak
AHAbdeddayem Haggui
Abdeddayem Haggui
AEAllouche Emna
Allouche Emna
SOSana Ouali
Sana Ouali
AHAfef Ben Halima
Afef Ben Halima
LZLilia Zakhama
Lilia Zakhama
Background: In Tunisia, the number of cardiac implantable electronic devices (CIEDs) is increasing, owing to the increase in patient life expectancy and expanding indications. Despite their life-saving potential and a significant reduction in population morbidity and mortality, their increased numbers have been associated with the development of multiple early and late complications related to vascular access, pockets, leads, or patient characteristics. Objective: The study aims to identify the rate, type, and predictors of complications occurring within the first year after CIED implantation. It also aims to describe the demographic and epidemiological characteristics of a nationwide sample of patients with CIED in Tunisia. Additionally, the study will evaluate the extent to which Tunisian electrophysiologists follow international guidelines for cardiac pacing and sudden cardiac death prevention. Methods: The Tunisian National Study of Cardiac Implantable Electronic Devices (NATURE-CIED) is a national, multicenter, prospectively monitored study that includes consecutive patients who underwent primary CIED implantation, generator replacement, and upgrade procedure. Patients were enrolled between January 18, 2021, and February 18, 2022, at all Tunisian public and private CIED implantation centers that agreed to participate in the study. All enrolled patients entered a 1-year follow-up period, with 4 consecutive visits at 1, 3, 6, and 12 months after CIED implantation. The collected data are recorded electronically on the clinical suite platform (DACIMA Clinical Suite). Results: The study started on January 18, 2021, and concluded on February 18, 2023. In total, 27 cardiologists actively participated in data collection. Over this period, 1500 patients were enrolled in the study consecutively. The mean age of the patients was 70.1 (SD 15.2) years, with a sex ratio of 1:15. Nine hundred (60%) patients were from the public sector, while 600 (40%) patients were from the private sector. A total of 1298 (86.3%) patients received a conventional pacemaker and 75 (5%) patients received a biventricular pacemaker (CRT-P). Implantable cardioverter defibrillators were implanted in 127 (8.5%) patients. Of these patients, 45 (3%) underwent CRT-D implantation. Conclusions: This study will establish the most extensive contemporary longitudinal cohort of patients undergoing CIED implantation in Tunisia, presenting a significant opportunity for real-world clinical epidemiology. It will address a crucial gap in the management of patients during the perioperative phase and follow-up, enabling the identification of individuals at particularly high risk of complications for optimal care. Trial Registration: ClinicalTrials.gov NCT05361759; https://classic.clinicaltrials.gov/ct2/show/NCT05361759 International Registered Report Identifier (IRRID): RR1-10.2196/47525

26 April 2023 in Population Medicine
Verified
Journal Article
Open access
AMAhmed Makni
Ahmed Makni
AGAimen Ghrab
Aimen Ghrab
SCSalma Charfeddine
Salma Charfeddine
STSlim Torjmen
Slim Torjmen
HHHassen Hadjamor
Hassen Hadjamor
LALeila Abid
Leila Abid
Background: It is established that Covid 19 infection causes endothelial dysfunction resulting in most of its acute symptoms and its long-term effects also known as post covid-19 syndrome. Aim: The aim of the study was to evaluate the effect of Sulodexide, a purified glycosaminoglycan...